| 标题 |
A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1–LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma |
| 网址 | |
| DOI |
10.1158/1078-0432.ccr-25-4478
doi
|
| 其它 |
期刊:Clinical Cancer Research 作者:Elena Garralda; Christoph Markert; V. Moreno; Emiliano Calvo; Kristoffer Rohrberg; et al 出版日期:2026-04-07 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)